Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival

Practical Radiation Oncology

Volumn 3, Issue 3, 2013, Pages 234-240

  Tward, Jonathan D ^a,b   Kokeny, Kristine E ^a,b   Shrieve, Dennis C ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON CANCER; CORRELATION ANALYSIS; FOLLOW UP; HEART DISEASE; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE ADENOCARCINOMA; UNIVARIATE ANALYSIS;

EID: 84879882587     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.11.011     Document Type: Article

References (20)

1. AJCC Cancer Staging Manual 2010, Spinger. 7th ed. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
2. Da Pozzo L.F., Cozzarini C., Briganti A., et al. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Eur Urol. 2009, 55:1003-1011.
3. Zagars G.K., Pollack A., von Eschenbach A.C. Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 2001, 58:233-239.
4. Sands M.E., Pollack A., Zagars G.K. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int J Radiat Oncol Biol Phys. 1995, 31:13-19.
5. Nguyen P.L., Chen M.H., Hoffman K.E., Katz M.S., D'Amico A.V. Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era. Int J Radiat Oncol Biol Phys. 2009, 74:104-109.
6. Paul A., Ploussard G., Nicolaiew N., et al. Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 Procedures. Eur Urol. 2009, 57:267-272.
7. Mohler J.L. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw. 2010, 8:145.
8. SEER website Available at, Accessed July 27, 2010. http://seer.cancer.gov/about/.
9. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958, 53:457-481.
10. Armitage P. Statistical Methods in Medical Research 1994, Blackwell, Oxford, UK.
11. Cox D.R. Regression models and life tables. J R Stat Soc B. 1972, 34:187-220.
12. Briganti A., Blute M.L., Eastham J.H., et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009, 55:1251-1265.
13. Messing E.M., Manola J., Yao J., et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol. 2006, 7:472-479.
14. Johnstone P.A., Assikis V., Goodman M., Ward K.C., Riffenburgh R.H., Master V. Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes. Prostate Cancer Prostatic Dis. 2007, 10:185-188.
15. Verhagen P.C., Schröder F.H., Collette L., Bangma C.H. Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review. Eur Urol. 2010, 58:261-269.
16. Bill-Axelson A., Holmberg L., Filén F.F., et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008, 100:1144-1154.
17. Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009, 373:301-308.
18. Lawton C.A., Bae K., Pilepich M., Hanks G., Shipley W. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. Int J Radiat Oncol Biol Phys. 2008, 70:437-441.
19. Deville C., Both S., Hwang W.T., Tochner Z., Vapiwala N. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010, 78:763-772.
20. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 70:1124-1129.